Literature DB >> 11088026

The effect of synthetic patch repair of coarctation on regional deformation of the aortic wall.

B H Smaill1, D C McGiffin, I J Legrice, A A Young, P J Hunter, A J Galbraith.   

Abstract

BACKGROUND: A long-term complication of synthetic patch repair of coarctation is true aneurysm formation. AIM: An in vitro study was undertaken to determine the effects of patch angioplasty on aortic geometry and strain adjacent to the patch.
METHODS: Segments of human descending thoracic aorta were subject to 10 pressure loading cycles (10-120 mm Hg; 1.36-16.32 kPa) before and after simulated coarctation repair with a synthetic patch. Local curvature and strain were estimated by fitting a geometric model to reconstructed three-dimensional surface marker points.
RESULTS: In the control aortas, when pressure increased from 11 +/- 1.0 to 124 +/- 4.0 mm Hg (1.5 +/- 0.14 to 16.86 +/- 0.54 kPa), average circumferential curvature decreased from 0.1543 +/- 0.03 to 0.1065 +/- 0.03 mm(-1). The average major extension reached a maximum of 1.43 +/- 0.08. After patch implantation, the average circumferential curvature was reduced relative to control at all pressures. Average major extensions were significantly greater than paired control values and reached a maximum of 1.55 +/- 0.08 at 122 +/- 4.0 mm Hg (16.59 +/- 0. 54 kPa). Substantial strain inhomogeneity was observed and major extensions were greatest immediately adjacent to the patch. INFERENCE: Synthetic patch repair of coarctation of the aorta increases wall strain and produces significant regional gradients in strain. With control aortic material properties there may be a substantial increase in wall stress immediately adjacent to the aorta, which could lead to true aneurysm formation.

Entities:  

Mesh:

Year:  2000        PMID: 11088026     DOI: 10.1067/mtc.2000.110187

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  Giant aneurysm 25 years after patch aortoplasty for aortic coarctation.

Authors:  Roberto Chiesa; Germano Melissano; Efrem Civilini; Luca Bertoglio; Francesco Setacci; Domenico Baccellieri
Journal:  Tex Heart Inst J       Date:  2008

2.  Long-term outcome of large artificial patch aortic repair for diffuse stenosis in Williams syndrome.

Authors:  Koichi Sughimoto; Yoshiharu Takahara; Kenji Mogi; Manabu Sakurai; Chikashi Aoki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-10-13

3.  Aortic aneurysms remain a significant source of morbidity and mortality after use of Dacron(®) patch aortoplasty to repair coarctation of the aorta: results from a single center.

Authors:  Jonathan W Cramer; Salil Ginde; Peter J Bartz; James S Tweddell; S Bert Litwin; Michael G Earing
Journal:  Pediatr Cardiol       Date:  2012-07-28       Impact factor: 1.655

4.  The Porcine Aortic Tissue Culture System in vitro for Stem Cell Research.

Authors:  Dong-Eun Kim; Keun-Hee Oh; Ji-Hye Yang; Sun-Keun Kwon; Tae-Jun Cho; Seul-Bi Lee; Hyun Nam; Dong-Sup Lee; Jung-Ryul Lee; Gene Lee; Jaejin Cho
Journal:  Int J Stem Cells       Date:  2011-11       Impact factor: 2.500

5.  Real-time aortic pulse wave velocity measurement during exercise stress testing.

Authors:  Paul A Roberts; Brett R Cowan; Yingmin Liu; Aaron C W Lin; Poul M F Nielsen; Andrew J Taberner; Ralph A H Stewart; Hoi Ieng Lam; Alistair A Young
Journal:  J Cardiovasc Magn Reson       Date:  2015-10-05       Impact factor: 5.364

6.  Successful implantation of a decellularized equine pericardial patch into the systemic circulation.

Authors:  Pascal Maria Dohmen; Francisco da Costa; Sergio Vega Lopes; Ricardo Vilani; Oliver Bloch; Wolfgang Konertz
Journal:  Med Sci Monit Basic Res       Date:  2014-01-10

7.  Endovascular treatment of late thoracic aortic aneurysms after surgical repair of congenital aortic coarctation in childhood.

Authors:  Robert Juszkat; Bartlomiej Perek; Bartosz Zabicki; Olga Trojnarska; Marek Jemielity; Ryszard Staniszewski; Wiesław Smoczyk; Fryderyk Pukacki
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.